Dose Response Trial of Pergolide for Cocaine Dependence – 1
Overview
The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.
Full Title of Study: “Dose Response Trial of Pergolide for Cocaine Dependence”
Study Type
- Study Type: Interventional
- Study Design
- Primary Purpose: Treatment
Interventions
- Drug: Pergolide
Clinical Trial Outcome Measures
Primary Measures
- Side effects
- Drug use
- Retention
- Cocaine withdrawal
- Compliance
- Effectiveness of medication for global improvements
Participating in This Clinical Trial
Please contact site for information.
Gender Eligibility: All
Minimum Age: 21 Years
Maximum Age: 50 Years
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Medical University of South Carolina
- Collaborator
- National Institute on Drug Abuse (NIDA)
- Overall Official(s)
- Robert Malcolm, M.D., Principal Investigator, Medical University of South Carolina
References
Malcolm R, Moore JW, Kajdasz DK, Cochrane CE. Pergolide mesylate. Adverse events occurring in the treatment of cocaine dependence. Am J Addict. 1997 Spring;6(2):117-23. doi: 10.3109/10550499709137022.
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.